Clinical Outcomes Before and After Prucalopride Treatment: An Observational Study in Patients With Chronic Idiopathic Constipation in the United States
Authors:
- Anthony LemboALAnthony Lembo
- Brooks D. CashBCBrooks D. Cash
- Mei LuMLMei Lu
- Emi TerasawaETEmi Terasawa
- Brian TerreriBTBrian Terreri
- Shawn DuSDShawn Du
- Rajeev AyyagariRARajeev Ayyagari
- Paul FeuerstadtPFPaul Feuerstadt
- Baharak MoshireeBMBaharak Moshiree
- Ben WestermeyerBWBen Westermeyer
- Selina PiSPSelina Pi
- Mena BoulesMBMena Boules
Open Access
- 15 February 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 15 (5) , e00687
Abstract
INTRODUCTION: This real-world US-based claims study compared constipation-related symptoms and complications 6 months before and after prucalopride initiation in adults with chronic idiopathic constipation (CIC). METHODS: This observational, retrospective cohort analysis used the IBM MarketScan Commercial Claims and Encounters Database and the Medicare Supplemental Database (January 2015–June 2020). Prucalopride-treated patients (≥18 years old) who had ≥1 constipation-related International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code during the baseline or study period were included. The proportions of patients with constipation-related symptoms (abdominal pain, abdominal distension [gaseous], incomplete defecation, and nausea) and constipation-related complications (anal fissure and fistula, intestinal obstruction, rectal prolapse, hemorrhoids, perianal venous thrombosis, perianal/perirectal abscess, and rectal bleeding) were examined. Constipation-related symptoms and complications were identified using ICD-10-CM, ICD-10-Procedure Coding System, or Current Procedural Terminology codes. Data were stratified by age (overall, 18–64 years, and ≥65 years). RESULTS: This study included 690 patients: The mean (SD) patient age was 48.0 (14.7) years, and 87.5% were women. The proportions of patients overall with constipation-related symptoms decreased 6 months after prucalopride initiation (abdominal pain [50.4% vs 33.3%, P < 0.001]; abdominal distension [gaseous] [23.9% vs 13.3%, P < 0.001]; and nausea [22.6% vs 17.7%, P < 0.01]; no improvements observed for incomplete defecation). Similarly, the proportions of patients overall with constipation-related complications decreased 6 months after prucalopride initiation (intestinal obstruction [4.9% vs 2.0%, P < 0.001]; hemorrhoids [10.7% vs 7.0%, P < 0.05]; and rectal bleeding [4.1% vs 1.7%, P < 0.05]). DISCUSSION: This study suggests that prucalopride may be associated with improved constipation-related symptoms and complications 6 months after treatment initiation.Keywords
Funding Information
- Takeda Pharmaceuticals U.S.A.
This publication has 19 references indexed in Scilit:
- Constipation and Laxative Use among Nursing Home Patients: Prevalence and Associations Derived from the Residents Assessment Instrument for Long-Term Care Facilities (interRAI LTCF)Gastroenterology Research and Practice, 2016
- Long‐term outcome of prucalopride for chronic constipation: a single‐centre studyColorectal Disease, 2015
- A randomized, double‐blind, placebo‐controlled trial to evaluate the efficacy, safety, and tolerability of long‐term treatment with prucaloprideNeurogastroenterology & Motility, 2015
- The association between prucalopride efficacy and constipation typeTechniques in Coloproctology, 2013
- Concurrent Conditions in Patients with Chronic Constipation: A Population–Based StudyPLOS ONE, 2012
- Clinical trial: the efficacy of open‐label prucalopride treatment in patients with chronic constipation – follow‐up of patients from the pivotal studiesAlimentary Pharmacology & Therapeutics, 2010
- Influence of Positive Family History on Clinical Characteristics of Functional ConstipationClinical Gastroenterology and Hepatology, 2007
- Chronic constipation: a survey of the patient perspectiveAlimentary Pharmacology & Therapeutics, 2007
- Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative DataMedical Care, 2005
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987